Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China
· Delayed Price · Currency is CNY 27.85
-0.11 (-0.39%)
Apr 30, 2026, 11:29 AM CST
SHA:688566 Revenue
Jiangsu Jibeier Pharmaceutical had revenue of 226.42M CNY in the quarter ending March 31, 2026, with 12.20% growth. This brings the company's revenue in the last twelve months to 990.68M, up 9.58% year-over-year. In the year 2025, Jiangsu Jibeier Pharmaceutical had annual revenue of 966.07M with 7.76% growth.
Revenue (ttm)
990.68M
Revenue Growth
+9.58%
P/S Ratio
5.63
Revenue / Employee
746.56K
Employees
1,326
Market Cap
5.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 966.07M | 69.53M | 7.76% |
| Dec 31, 2024 | 896.53M | 35.60M | 4.14% |
| Dec 31, 2023 | 860.93M | 206.20M | 31.49% |
| Dec 31, 2022 | 654.73M | 145.04M | 28.46% |
| Dec 31, 2021 | 509.69M | -56.28M | -9.94% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.68B |
| Jiangsu Lianhuan Pharmaceutical | 2.71B |
| Luoxin Pharmaceuticals Group Stock | 2.37B |
| Chongqing Pharscin Pharmaceutical | 827.14M |
| HPGC Renmintongtai Pharmaceutical | 10.54B |
| Guizhou Xinbang Pharmaceutical | 5.62B |
| Tianjin Lisheng Pharmaceutical | 1.35B |
| Jinghua Pharmaceutical Group | 1.46B |